Servier Affaires Medicales
$70.3K 25 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Silony Medical Corp.
Silony Medical Corp. reported $70,717.80 across General Payments, Research, and Ownership to 9 physicians and teaching hospitals across 9 transactions.
- $70.7K Below-median payer
- All-tracks total
- 9 Below-median volume
- Transactions
- 9 Below-median reach
- Recipients
- +$9.6K
- General Payments vs PY2023
Silony Medical Corp. reported $70,717.80 across all CMS Open Payments tracks (General + Research + Ownership) to 9 physicians and teaching hospitals in Program Year 2024 - ranking #1268 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $70,717.80, averaging $7.9K per recipient.
Silony Medical Corp.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
10/100
Total payments
F
11/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
10/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer silony-medical-corp Silony Medical Corp.
$70.7K · #1268/1,925 · 0.0% industry · PY2024
- TOT $70.7K
- RANK #1268
- SHARE 0.0%
- TXN 9
- RCP 9
- CAT 1
- GEN $70.7K
- ΔGEN +$9.6K
- TOP1 57.5%
- PY 2024
Volume peers
Nearest volume peer: Servier Affaires Medicales ($70.3K)
Silony Medical Corp. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Silony Medical Corp.'s CMS-reported General Payments increased by $9.6K (+15.7%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: SILONY MEDICAL CORP.PY2023: SILONY MEDICAL CORP.PY2024: Silony Medical Corp.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $61,103.14
- PY2024
- $70,717.80
What the Data Shows for Silony Medical Corp.
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Silony Medical Corp. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
"Royalty or License" leads the 1-category general-payment breakdown below at $70.7K (100.0% of General Payments, 9 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
"Royalty or License" leads Silony Medical Corp.'s 1-category general-payment breakdown at $70.7K, 100.0% of the reported total.
How Silony Medical Corp. divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Royalty or License | $70.7K | 9 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $70,717.80 (100.0%) of $70,717.80 in this company's General Payments records across 3 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Silony Medical Corp.
The five named recipients with the highest reported General Payments from this company
- 1
Jon White
$40,689.43 across 4 reported transactions
- 2
Said Elshihabi
$23,402.14 across 4 reported transactions
- 3
Jason Garber
$6,626.23 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Silony Medical Corp. ranks #1268 of 1,925 by total payments (bottom 34% by spend) but is notably more concentrated than that alone would suggest -- #411 of 1,838 by HHI (top 22% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Cala Health, Inc. : $93.4K total payments, HHI 4549
- Draeger Medical Systems, Inc : $61.0K total payments, HHI 4539
- Konica Minolta Healthcare Americas, Inc : $40.7K total payments, HHI 4538
- HealthTronics Stone Solutions, LLC : $3.2K total payments, HHI 4526
- MicroPort CRM USA Inc : $131.67 total payments, HHI 4523
- VentureMed Group, Inc. : $53.9K total payments, HHI 4505
- Silony Medical Corp. (this company) : $70.7K total payments, HHI 4493
- Pillar Biosciences, Inc : $3.3K total payments, HHI 4491
- AnX Robotica Corp : $31.6K total payments, HHI 4488
- American National Red Cross : $2.1K total payments, HHI 4487
- Elekta LTD : $857.01 total payments, HHI 4470
- Pfizer S.a. : $11.9K total payments, HHI 4469
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Silony Medical Corp.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Silony Medical Corp..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Silony Medical Corp..
Showing 6 of 1,924 companies with CMS-reported payment data.
Grifols, S.A.
$70.2K 19 recipients
Compare payment profiles
Institut de Recherches Internationales Servier
$71.4K 0 recipients
Compare payment profiles
Biocircuit Technologies Inc
$69.8K 112 recipients
Compare payment profiles
Baylis Medical Technologies Inc.
$71.7K 168 recipients
Compare payment profiles
Coastal Medical Technologies Llc
$69.5K 1,265 recipients
Compare payment profiles
Put this to use
Silony Medical Corp. ranks #1268 of 1,925 by all-tracks total payments, led by "Royalty or License".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Royalty or License" spend across every manufacturer, not just Silony Medical Corp.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.